Dent R, Cortes J, Pusztai L, McArthur H, et al. Neoadjuvant pembrolizumab+chemotherapy/adjuvant pembrolizumab for Early-Stage Triple-Negative breast cancer: Quality-of-Life results from randomized KEYNOTE-522 study. J Natl Cancer Inst 2024 Jun 24:djae129. doi: 10.1093.
PMID: 38913881